(Z)-1-Chloro-2,3,3-trifluoroprop-1-ene (contains ca. 10% (E)- isomer)>89.0%(GC)500g

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 1mg

2-Chloro-3,4-dimethylpyridine, 95.0%, 100mg

1-Cyclohexyl-2,2,2-trifluoroethan-1-ol, 98%, 5g

(E)-4-(4-(2-((TERT-BUTOXYCARBONYL)AMINO)ETHYL)PIPERAZIN-1-YL)BUT-2-ENOIC ACID, 97%, 250mg

(S)-tert-Butyl 3-formylmorpholine-4-carboxylate, 95.0%, 1g

TAXIFOLIN, 95%, 250mg

3,3-Difluoroazetidine hydrochloride, 98.0%, 10g

2',4'-Dimethoxy-biphenyl-4-ylaminehydrochloride, 1g

3-Fluorothioanisole, 98.0%, 5g

1,4,5,6,7,8-Hexahydrocyclohepta[c]pyrazole-3-carboxylic acid, 97%, 1g

1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea, 100mg

(4-nitrobenzyl)1,2,3,4-tetrahydronaphthalen-1-ylamine, 95.0%, 1g